当前位置: 首页 > 期刊 > 《第四军医大学学报》 > 2005年第6期
编号:10969857
地塞米松前体药在大鼠体内的药代动力学
http://www.100md.com 《第四军医大学学报》 2005年第6期
结肠靶向药物前体,,结肠靶向药物前体;地塞米松;药代动力学,1材料和方法,2结果,3讨论,【参考文献】
     Pharmacokinetic study of dexamethasonesuccinatedextran prodrug in rats

    LIU XinYou,ZHOU SiYuan,RAN YuHua,MEI QiBing

    Department of Pharmacology,School of Pharmacy,Fourth Military Medical University,Xian 710033,China

    【Abstract】 AIM: To study the pharmacokinetics of dexamethasonesuccinatedextran (average Mr of dextran 76 000) prodrug in rats.METHODS: Dexamethasone (Dex) and the prodrug were orally administered to rats at the dose of 5 μmol/kg,respectively.The drug in the plasma and in the content of different parts of the rat GI tract was determined by high performance liquid chromatography (HPLC).RESULTS: Dex was mainly released in the contents and mucosa of cecum and colon after oral administration of prodrug and its absorption was reduced significantly.The peak time,peak concentration and AUC were 62 h,149 μg/L and 1364 μg/(h·L),respectively.Free Dex was found mainly in the contents and mucosa of the stomach,and proximal and distal small intestine after oral administration.The peak time,peak concentration and AUC were 22 h,2120 μg/L and 11 875 μg/(h·L),respectively.CONCLUSION: Dex can be specifically delivered to the cecum and colon by using dexamethasonesuccinatedextran prodrug.The absorption of Dex is reduced significantly and the drug concentration in colon increases.The prodrug holds a potential for the treatment of inflammatory bowel disease. ......

您现在查看是摘要页,全文长 9844 字符